Varun Debbeti
Varun Debbeti is a statistical programming professional with over a decade of experience supporting Phase 1 through Phase 4 oncology clinical trials within the pharmaceutical industry. He has contributed to clinical data programming and regulatory submission activities supporting approvals by the FDA and the EMA), including work associated with Ogsiveo® for desmoid tumors and the Biologics License Application (BLA) submission for YESCARTA®, developed by Kite Pharma for the treatment of certain forms of non-Hodgkin lymphoma. In addition to his industry experience, he is the founder of ClinStandards.org, an educational non-profit platform where he writes technical articles on evolving CDISC data standards and open-source AI tools for the clinical research community.
Contributing Author
Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
